FBC advises the Orbimed Fund in an investment in Keystone Heart

By Raz Tepper | May 2014 | Transaction

FBC advises Orbimed in an investment in Keystone Heart, which develops and manufactures embolic cerebral protection devices to reduce the risk of stroke, neurocognitive decline and dementia caused by brain emboli associated with cardiovascular procedures.